Dr Jeremy Thomas is a Consultant Pathologist with active resercah interests in breast cancer, including:
Screen-detected ductal carcinoma in citu (DCIS) including diagnosis and staging.
Quality assurance in breast cancer receptor testing.
Translational breast cancer research including pathology support for large clinical trials: Supremo, Artemis and Rosco.
Pathological evaluation of tissues following neoadjuvant chemotherapy.
Management of the axilla in breast cancer.
He is also a member of the Sloane Project Steering Group which has been studying UK screen-detected DCIS for the last ten years with a study cohort of over 12000 patients.
Breast cancer pathology educational resource: